Pancreatic cancer organoids recapitulate disease and allow personalized drug screening

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2019-12-09

DOI: 10.1073/pnas.1911273116

Affiliations: 15

Authors: 22

Go to article
Institutions Share
University Medical Center Utrecht (UMC Utrecht), Netherlands 0.32
Oncode Institute, Netherlands 0.15
Division of Molecular Carcinogenesis, NKI, Netherlands 0.14
Hubrecht Organoid Technology (The HUB), Netherlands 0.14
Wellcome Sanger Institute, United Kingdom (UK) 0.09
UMC Section Molecular Cancer Research, Netherlands 0.07
Hubrecht Institute: Developmental Biology and Stem Cell Research, KNAW, Netherlands 0.05
UMC Utrecht Center for Molecular Medicine (CMM), Netherlands 0.02
Hartwig Medical Foundation, Netherlands 0.01
Center for Personalized Cancer Treatment (CPCT), Netherlands 0.01
Princess Maxima Centre for Pediatric Oncology (PMC), Netherlands 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER